State Street Portfolio holdings
State Street Corporation, established in 1792 and headquartered in Boston, Massachusetts, is one of the oldest financial institutions in the United States and a major player in the global asset management and custody banking sectors. Primarily known for its custodial services, it safeguards assets for institutional investors, managing trillions of dollars through its State Street Global Advisors (SSGA) division, which is renowned for launching the first U.S. exchange-traded fund (ETF), the SPDR S&P 500 ETF (SPY), in 1993. The company provides a range of services including investment management, research, trading, and data analytics, catering mostly to institutional clients like pension funds, endowments, and mutual funds. With a focus on financial infrastructure and innovation, State Street has positioned itself as a key backbone in the global investment ecosystem.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$3.42B |
| 2 |
Cigna
CI
|
+$1.25B |
| 3 |
CVS Health
CVS
|
+$1.25B |
| 4 |
Marathon Petroleum
MPC
|
+$805M |
| 5 |
Diamondback Energy
FANG
|
+$589M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$3.86B |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$2.31B |
| 3 |
PX
Praxair Inc
PX
|
+$2.1B |
| 4 |
Apple
AAPL
|
+$1.38B |
| 5 |
ANDV
Andeavor
ANDV
|
+$1.1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.79% |
| 2 | Technology | 15.42% |
| 3 | Healthcare | 14.78% |
| 4 | Industrials | 11.06% |
| 5 | Consumer Discretionary | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Ubiquiti
UI
$34.3B
| $24.1M | ﹤0.01% |
242,504
-65,802
| -21% | -$6.51M |
|
1827
GDS Holdings
GDS
$6.41B
| $24M | ﹤0.01% |
1,038,446
+22,106
| +2% | +$576K |
|
1828
Methode Electronics
MEI
$592M
| $24M | ﹤0.01% |
1,029,410
+8,229
| +0.8% | +$232K |
|
|
DOOR
1829
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $24M | ﹤0.01% |
534,571
-35,317
| -6% | -$1.91M |
|
1830
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.85B
| $24M | ﹤0.01% |
1,097,544
-110,057
| -9% | -$2.54M |
|
|
PRFT
1831
DELISTED
Perficient Inc
PRFT
| $23.9M | ﹤0.01% |
1,075,717
-63,371
| -6% | -$1.56M |
|
1832
Coherus Oncology
CHRS
$196M
| $23.9M | ﹤0.01% |
2,644,123
+464,506
| +21% | +$5.37M |
|
|
VIVO
1833
DELISTED
Meridian Bioscience Inc
VIVO
| $23.9M | ﹤0.01% |
1,377,667
-21,636
| -2% | -$369K |
|
1834
OneMain Financial
OMF
$7.47B
| $23.8M | ﹤0.01% |
978,897
+8,588
| +0.9% | +$244K |
|
|
CRAY
1835
DELISTED
Cray, Inc.
CRAY
| $23.8M | ﹤0.01% |
1,101,056
+4,610
| +0.4% | +$104K |
|
1836
ICF International
ICFI
$1.72B
| $23.8M | ﹤0.01% |
366,156
-8,453
| -2% | -$592K |
|
1837
Extreme Networks
EXTR
$3.15B
| $23.7M | ﹤0.01% |
3,885,249
-118,000
| -3% | -$684K |
|
|
TLRD
1838
DELISTED
Tailored Brands, Inc.
TLRD
| $23.7M | ﹤0.01% |
1,736,613
+42,869
| +3% | +$883K |
|
1839
Karyopharm Therapeutics
KPTI
$48M
| $23.6M | ﹤0.01% |
168,225
+38,845
| +30% | +$6.55M |
|
1840
State Street SPDR MSCI ACWI Climate Paris Aligned ETF
NZAC
$199M
| $23.6M | ﹤0.01% |
1,194,400
-532,000
| -31% | -$11.3M |
|
1841
MGP Ingredients
MGPI
$375M
| $23.6M | ﹤0.01% |
413,761
+30,736
| +8% | +$2.07M |
|
|
VBTX
1842
DELISTED
Veritex Holdings
VBTX
| $23.5M | ﹤0.01% |
1,099,336
+194,021
| +21% | +$4.74M |
|
1843
CTS Corp
CTS
$1.89B
| $23.5M | ﹤0.01% |
905,135
-14,728
| -2% | -$418K |
|
|
PGTI
1844
DELISTED
PGT, Inc.
PGTI
| $23.3M | ﹤0.01% |
1,470,740
+39,606
| +3% | +$766K |
|
1845
Enovis
ENOV
$1.53B
| $23.3M | ﹤0.01% |
647,165
-22,959
| -3% | -$1.07M |
|
1846
Installed Building Products
IBP
$6.49B
| $23.3M | ﹤0.01% |
690,796
-15,190
| -2% | -$528K |
|
1847
Spectrum Brands
SPB
$2.07B
| $23.3M | ﹤0.01% |
550,386
+3,260
| +0.6% | +$188K |
|
1848
CytomX Therapeutics
CTMX
$754M
| $23.3M | ﹤0.01% |
1,539,950
-441,600
| -22% | -$6.55M |
|
1849
ATN International
ATNI
$492M
| $23.2M | ﹤0.01% |
324,265
+7,206
| +2% | +$563K |
|
|
GTHX
1850
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $23.2M | ﹤0.01% |
1,212,339
+392,737
| +48% | +$14.7M |
|
Similar funds
State Street's Q4 2018 Portfolio in Review
As of Q4 2018, State Street held 3,872 positions worth $1.1T, down 16% from $1.3T the previous quarter. Its ten largest holdings account for 17% of the portfolio.
State Street's Q4 2018 filing shows 102 new, 1,442 increased, 2,108 reduced and 110 closed positions. Its largest new stake was Linde: 21,625,224 shares worth $3.37B. The largest sale was Aetna Inc, an estimated $3.86B.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 16% a quarter earlier, followed by Technology and Healthcare.
- State Street's largest Q4 2018 buy was Linde: 21,625,224 shares worth $3.37B.
- State Street added most to Cigna in Q4 2018, an estimated $1.25B increase.
- State Street's biggest Q4 2018 reduction was Apple, cutting an estimated $1.38B.
- State Street fully exited Aetna Inc in Q4 2018, selling an estimated $3.86B.
- State Street's ten largest holdings make up 17% of its $1.1T portfolio in Q4 2018.
- State Street opened 102 new positions and closed 110 in Q4 2018.
- State Street's portfolio value fell 16% quarter-over-quarter to $1.1T.
Based on State Street's 13F filing for Q4 2018, filed 12 Feb 2019.